J. W. Chang

发表

Cost‐effectiveness of bevacizumab‐based therapy versus cisplatin plus pemetrexed for the first‐line treatment of advanced non‐squamous NSCLC in Korea and Taiwan

M. Ahn, Chun-Ming Tsai, T. Hsia, 2011, Asia-Pacific journal of clinical oncology.

Real-world Afatinib Outcomes in Advanced Non–small Cell Lung Cancer Harboring EGFR Mutations

Yueh-Fu Fang, Cheng-Ta Yang, Ching-Fu Chang, 2022, AntiCancer Research.

Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients

Cheng-Ta Yang, Ching-Fu Chang, Chiao-En Wu, 2022, Thoracic cancer.

Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma.

T. Kuo, Chih-hsun Yang, H. Hong, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In vitro and in vivo study of GSK2830371 and RG7388 combination in liver adenocarcinoma.

J. Lunec, Jen‐Shi Chen, C. Yeh, 2022, American journal of cancer research.

Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations

Cheng-Ta Yang, Ching-Fu Chang, Chiao-En Wu, 2022, Therapeutic advances in respiratory disease.

Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan

Cheng-Ta Yang, Ching-Fu Chang, Chiao-En Wu, 2022, Thoracic cancer.

Severe photosensitivity reaction to vandetanib.

Chih-hsun Yang, Chih-Hsiang Chang, J. W. Chang, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Regressed Subungual Melanoma Simulating Cellular Blue Nevus: Managed with Sentinel Lymph Node Biopsy

T. Kuo, Chih-hsun Yang, Y. Lo, 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Sunrise in melanoma management: Time to focus on melanoma burden in Asia

N. Yamazaki, V. Sriuranpong, B. Dhabhar, 2017, Asia-Pacific journal of clinical oncology.

Transcriptomic Analysis in Liquid Biopsy Identifies Circulating PCTAIRE-1 mRNA as a Biomarker in NSCLC

Chia-Jung Yu, Ji-Dung Luo, C. Chiou, 2019, Cancer Genomics & Proteomics.

Prognostic Implications of Epidermal Growth Factor Receptor and KRAS Gene Mutations and Epidermal Growth Factor Receptor Gene Copy Numbers in Patients with Surgically Resectable Non-small Cell Lung Cancer in Taiwan

Hsin-Yi Yang, Shiu-Feng Huang, Yi-cheng Wu, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications

Shiu-Feng Huang, Hui-ping Liu, Hui-Yu Hsu, 2008, Cancer.

A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan

T. Kuo, C. Hsieh, J. Hsieh, 2016, Asia-Pacific journal of clinical oncology.

Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI

Yueh-Fu Fang, Cheng-Ta Yang, Ching-Fu Chang, 2022, Cancers.

Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung Adenocarcinoma

Cheng-Ta Yang, Ching-Fu Chang, Chiao-En Wu, 2022, Cancers.

WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells

J. Lunec, Jen‐Shi Chen, C. Yeh, 2021, Cancers.

Efficacy and safety of bio‐chemotherapy with dacarbazine plus interleukin‐2 in patients with unresectable malignant melanoma

Hung-Ming Wang, J. W. Chang, Wen-Kuan Huang, 2015, Asia-Pacific journal of clinical oncology.

Sentinel Lymph Node Biopsy Was Associated With Favorable Survival Outcomes For Patients With Clinically Node-Negative Asian Melanoma

T. Ho, Chiao-En Wu, Y. Lo, 2019, Cancer management and research.

Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy

W. Chou, Jen‐Shi Chen, C. Hsieh, 2021, Cancers.

Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience

W. Chou, Jen‐Shi Chen, C. Hsieh, 2020, BMC Cancer.

Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer Patients

Cheng-Ta Yang, Ching-Fu Chang, Chiao-En Wu, 2022, Cancers.

Safety of Tepotinib Challenge after Capmatinib-Induced Pneumonitis in a Patient with Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation: A Case Report

Chiao-En Wu, J. W. Chang, Liang-Wei Tseng, 2022, International journal of molecular sciences.

An indirect comparison of bevacizumab plus cisplatin‐gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first‐line non‐squamous non‐small cell lung cancer in East Asia

M. Ahn, S. Thongprasert, S. Walzer, 2011, Asia-Pacific journal of clinical oncology.

Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma.

Joseph T. Chang, Hung-Ming Wang, S. Ng, 2013, Biomedical journal.

Radiation Recall Pneumonitis: A Rare Syndrome That Should Be Recognized

P. Jan, Chiao-En Wu, J. W. Chang, 2022, Cancers.

Histopathological and CT features of pulmonary sclerosing haemangiomas.

S. Ng, Y. Cheung, J. W. Chang, 2003, Clinical radiology.

Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma.

Joseph T. Chang, Hung-Ming Wang, S. Ng, 2013, Biomedical journal.

Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR ‐mutated NSCLC treated with afatinib

Chen-Te Wu, Ching-Fu Chang, Chiao-En Wu, 2023, Thoracic cancer.

The survival after discontinuation of EGFR‐TKIs due to intolerable adverse events in patients with EGFR‐mutated non–small cell lung cancer

Cheng-Ta Yang, Ching-Fu Chang, Chiao-En Wu, 2022, Thoracic cancer.

Generation and validation of a predictive model for estimating survival among patients with EGFR-mutant non-small cell lung cancer.

P. Su, Ching-Fu Chang, Chiao-En Wu, 2023, American journal of cancer research.